Hyperhomocysteinemia

From Wikipedia, the free encyclopedia

Hyperhomocysteinemia
Classification and external resources
Homocysteine
DiseasesDB 29853
eMedicine neuro/578 

Hyperhomocysteinemia is a medical condition characterized by an abnormally large level of homocysteine in the blood.

As a consequence of the biochemical reactions in which homocysteine is involved, deficiencies of the vitamins folic acid, pyridoxine (B6), or B12 can lead to high homocysteine levels.[1] Supplementation with pyridoxine, folic acid, B12 or trimethylglycine (betaine) reduces the concentration of homocysteine in the bloodstream.[2]

Normal fasting homocysteine plasma levels are between 5,0 and 15,9 mmol/l.

[edit] See also

Hyperhomocysteinemia is a risk factor for coronary artery disease and in cases of young myocardial infarction the level is found to be elevated.

[edit] References

  1. ^ Miller JW, Nadeau MR, Smith D, Selhub J (1994). "Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats". American Journal of Clinical Nutrition 59: 1033–1039. PMID 8172087. 
  2. ^ van Guldener C, Stehouwer CD (2001). "Homocysteine-lowering treatment: an overview". Expert Opinion on Pharmacotherapy 2 (9): 1449–1460. doi:10.1517/14656566.2.9.1449. PMID 11585023. 
Languages